Search Within

Guilherme Harada

  1. "Cancer Biology and Genetics Program Faculty"
Formats
  1. Journal Article (1)
Groups
  1. Cancer Biology and Genetics Program Faculty (1)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (1)
  3. Department of Medicine (1)
  4. Department of Pathology and Laboratory Medicine (1)
  5. GME, Medicine (1)
  6. GSK Faculty (1)

More Groups

People
  1. Alexander Drilon (1)
  2. Amanda Kulick (1)
  3. Andrea Ventura (1)
  4. Elisa De Stanchina (1)
  5. Matteo Repetto (1)
  6. Soo Ryum Yang (1)
Years
  1. 2024 (1)
Publications
  1. British Journal of Cancer (1)
Publishers
  1. Nature Publishing Group (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents
    Journal Article

    Roa, P.; Foglizzo, V.; Harada, G.; Repetto, M.; Kulick, A.; de Stanchina, E.; de Marchena, M.; Auwardt, S.; Sayed Ahmed, S.; Bremer, N. V.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save